Ankylosing Spondylitis News

Simponi Aria Approved for Psoriatic Arthritis, Ankylosing Spondylitis - Managed Care magazine



Simponi Aria Approved for Psoriatic Arthritis, Ankylosing Spondylitis 
Managed Care magazine
The FDA has approved golimumab (Simponi Aria, Janssen Biotech, Inc.) for the treatment of adults with active psoriatic arthritis (PsA) or active ankylosing spondylitis (AS). Golimumab is a fully-human anti-tumor necrosis factor (TNF)-alpha therapy ...

 


Janssen (JNJ) Receives Two US FDA Approvals For SIMPONI ARIA For Treatment of Adults With Active PsA or Active ... - StreetInsider.com



Janssen (JNJ) Receives Two US FDA Approvals For SIMPONI ARIA For Treatment of Adults With Active PsA or Active ... 
StreetInsider.com
"Ankylosing spondylitis is a disease that adversely affects quality of life and the choices for treating this disabling condition are limited; The approval of IV golimumab for the treatment of active ankylosing spondylitis provides a welcomed new ...
FDA Approves Golimumab for 2 New Indications MD Magazine

all 3 news articles » 


TNF Blockers and Reduced Spinal Radiographic Progression in Ankylosing Spondylitis - Rheumatology Advisor



TNF Blockers and Reduced Spinal Radiographic Progression in Ankylosing Spondylitis 
Rheumatology Advisor
Data suggest that the use of tumor necrosis factor inhibitor (TNFi) therapy in patients with ankylosing spondylitis (AS) has an inhibitory effect on spinal radiographic progression if treatment continues for 2 years, and that this effect is mediated by ...

 


Improvements seen for patients with ankylosing spondylitis kyphosis after spinal osteotomy - Healio



Improvements seen for patients with ankylosing spondylitis kyphosis after spinal osteotomy 
Healio
PHILADELPHIA ? According to a presenter at the Scoliosis Research Society Annual Meeting, spinal osteotomy may improve quality of life for patients with ankylosing spondylitis kyphosis. ?From our series of clinical research, we had to know what is the ...

 


Patients with Rheumatic Diseases Bail on Biosimilars - MedPage Today



Patients with Rheumatic Diseases Bail on Biosimilars 
MedPage Today
Almost one-quarter (24%) of patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis who switched from infliximab (Remicade) to its biosimilar CT-P13 discontinued the biosimilar by 6 months, primarily for subjective reasons ...
Subjective complaints may cause patients to stop treatment after switching to a biosimilar DeathRattleSports.com

all 2 news articles » 


Perioperative Blood Loss During Total Hip Arthroplasty Among Patients With Ankylosing Spondylitis - Healio



Healio
 
Perioperative Blood Loss During Total Hip Arthroplasty Among Patients With Ankylosing Spondylitis 
Healio
Intraoperative blood loss is frequently an overarching concern during total hip arthroplasty (THA) for patients who have ankylosing spondylitis with hip involvement. However, the factors that affect blood loss have not been identified. The goal of this ...

 


Pugs and their people take over Surry, Maine | The Battle Within - Bangor Daily News



Bangor Daily News
 
Pugs and their people take over Surry, Maine | The Battle Within 
Bangor Daily News
On Saturday, October 14, over 60 pugs and their people, as well as countless pug lovers congregated in the town of Surry at the town wharf for a first annual Pug ...

and more » 


Biomarkers of Peripheral and Axial Arthritis in Psoriatic Disease - Rheumatology Advisor



Biomarkers of Peripheral and Axial Arthritis in Psoriatic Disease 
Rheumatology Advisor
... identified bone-turnover biomarkers for psoriatic disease-associated arthritis and axial arthritis, making it possible to distinguish among patients with psoriasis, those with psoriatic arthritis (PsA), and those with axial disease vs ankylosing ...

 


First Ever Psoriatic Arthritis and Ankylosing Spondylitis Patient Guidelines Published by CreakyJoints - Business Wire (press release)



First Ever Psoriatic Arthritis and Ankylosing Spondylitis Patient Guidelines Published by CreakyJoints 
Business Wire (press release)
UPPER NYACK, N.Y.--(BUSINESS WIRE)--CreakyJoints® today announced the expansion of their patient guideline library with the publication of ?A Patient's Guide to Living With Psoriatic Arthritis,? and ?A Patient's Guide to Living with Ankylosing Spondylitis.

and more » 


FDA Roundup of the Week: October 20 - MD Magazine



MD Magazine
 
FDA Roundup of the Week: October 20 
MD Magazine
The FDA approved the rheumatoid arthritis therapy for supplemental indications including psoriatic arthritis in adults with active ankylosing spondylitis. It is the only fully-human anti-tumor necrosis factor alpha therapy administered with a 30-minute ...